Lepore, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.913
EU - Europa 1.451
AS - Asia 1.368
SA - Sud America 286
AF - Africa 30
OC - Oceania 3
Totale 5.051
Nazione #
US - Stati Uniti d'America 1.854
SG - Singapore 597
DE - Germania 511
CN - Cina 286
BR - Brasile 224
SE - Svezia 199
IT - Italia 167
VN - Vietnam 154
FR - Francia 141
UA - Ucraina 95
GB - Regno Unito 81
FI - Finlandia 64
IN - India 62
BD - Bangladesh 54
IE - Irlanda 49
HK - Hong Kong 39
ID - Indonesia 38
JP - Giappone 38
CA - Canada 27
RU - Federazione Russa 26
AR - Argentina 25
PL - Polonia 21
MX - Messico 19
BE - Belgio 18
ES - Italia 17
IQ - Iraq 16
TR - Turchia 16
CO - Colombia 14
NL - Olanda 14
IR - Iran 12
KR - Corea 10
ZA - Sudafrica 10
PH - Filippine 9
AT - Austria 7
CZ - Repubblica Ceca 7
CL - Cile 6
EC - Ecuador 6
PT - Portogallo 6
SA - Arabia Saudita 6
TW - Taiwan 6
CH - Svizzera 5
DZ - Algeria 5
TN - Tunisia 5
UZ - Uzbekistan 5
BY - Bielorussia 4
GR - Grecia 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
VE - Venezuela 4
AU - Australia 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
MQ - Martinica 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.051
Città #
Singapore 313
Chandler 267
San Jose 178
Ashburn 171
Los Angeles 77
New York 61
Beijing 60
Ann Arbor 56
Jacksonville 55
Ho Chi Minh City 54
San Mateo 49
Dublin 46
Hanoi 42
Hefei 40
Milan 40
Marseille 39
Helsinki 36
Hong Kong 36
Tokyo 36
Lauterbourg 34
Jakarta 30
Dallas 29
Munich 29
Nanjing 29
Rome 28
Santa Clara 28
Boston 27
The Dalles 23
Wilmington 22
Nanchang 21
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Frankfurt am Main 18
São Paulo 18
Brussels 17
Houston 17
Nürnberg 17
Council Bluffs 16
Moscow 16
Buffalo 14
Redmond 14
Seattle 14
Augusta 13
Dhaka 12
Fairfield 12
Warsaw 12
Pune 11
Brooklyn 10
Kent 10
Seoul 10
Atlanta 9
Chennai 9
Lancaster 9
Lawrence 9
Orem 9
Paris 9
Andover 8
Da Nang 8
Izmir 8
London 8
Mexico City 8
Montreal 8
St Louis 8
Amsterdam 7
Bucaramanga 7
Denver 7
Düsseldorf 7
Madrid 7
Boardman 6
Bremen 6
Detroit 6
Hebei 6
Lappeenranta 6
Leawood 6
Manchester 6
Poplar 6
Redwood City 6
Taichung 6
Turku 6
Brno 5
Bắc Ninh 5
Hangzhou 5
Kish 5
Rio de Janeiro 5
Shanghai 5
Shenyang 5
Tashkent 5
University Park 5
Baghdad 4
Bogotá 4
Busto Arsizio 4
Charlotte 4
Chicago 4
Fremont 4
Johannesburg 4
Kunming 4
Las Vegas 4
Mumbai 4
Totale 2.580
Nome #
Cortical visual function in preterm infants in the first year. 277
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 225
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 221
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 214
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 201
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 199
Early visual and neuro-development in preterm infants with and without retinopathy 176
An epidemiological analysis of retinopathy of prematurity over 10 years. 164
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 161
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 158
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 157
A cost effectiveness analysis of cataract surgery 151
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 135
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 135
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 135
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 134
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 125
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 123
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications 116
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 113
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 110
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 104
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 103
International Classification of Retinopathy of Prematurity, Third Edition 102
The role of retinal imaging in the management of abusive head trauma cases 102
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial 93
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next 92
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial 92
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 89
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial 82
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 82
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 81
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial 78
Ranibizumab population pharmacokinetics and free vegf pharmacodynamics in preterm infants with retinopathy of prematurity in the rainbow trial 75
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis 72
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 71
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial 69
Early angiographic signs of retinopathy of prematurity requiring treatment 63
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study 63
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 62
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 59
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity 56
Totale 5.120
Categoria #
all - tutte 20.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024289 20 75 23 11 5 57 14 3 5 19 36 21
2024/2025695 13 18 56 23 38 28 35 26 126 63 143 126
2025/20262.020 284 73 122 224 273 102 339 117 154 132 106 94
2026/202747 47 0 0 0 0 0 0 0 0 0 0 0
Totale 5.120